uniQure N.V (QURE) - 68.14% Below 52-Week High: Buy or Wait?

Stock Details

uniQure N.V. (QURE), a prominent company in the healthcare sector within the biotechnology industry, is based in Netherlands and primarily trades on the NMS.Currently, the stock is trading at $22.78. Over the past 52 weeks, it has ranged between $8.73 and $71.50. This places the current price at 31.9% of its 52-week high and 160.9% above its 52-week low. Recent trading volume was recorded at 884,436. The 14-day Relative Strength Index (RSI) stands at 28.12, suggesting oversold conditions. The stock is currently trading below its 50-day moving average of $36.97 by 38.38%. Similarly, it is below its 200-day moving average of $29.62 by 23.09%. The MACD histogram is 0.76, indicating bullish momentum (MACD Line: -4.14, Signal Line: -4.89). There are currently 2 active alerts set for QURE by users.

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-7.56

Price to Book

4.80

EV/EBITDA

-7.09

EPS (TTM)

-$4.03

Price to Sales

83.33

Beta

1.06

Similar volatility to market

Q:How is QURE valued relative to its earnings and growth?

Valuation data is not available for this stock.

Q:What is QURE's risk profile compared to the market?

With a beta of 1.06, uniQure N.V. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 4.80 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-872.23%

EBITDA

$-182,916,000

Return on Equity

-157.61%

Return on Assets

-15.72%

Revenue Growth (YoY)

11.00%

Q:How profitable and efficient is QURE's business model?

0 The operating margin of -872.23% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -157.61% and ROA at -15.72%, the company achieves moderate returns on invested capital.

Q:What are QURE's recent growth trends?

uniQure N.V.'s revenue grew by 11.00% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. These growth metrics should be evaluated against Biotechnology industry averages for proper context.

Company Size & Market

Market Cap

$1.6B

Revenue (TTM)

$18.67M

Revenue/Share (TTM)

$0.30

Shares Outstanding

69.37M

Book Value/Share

$4.67

Asset Type

EQUITY

Q:What is QURE's market capitalization and position?

uniQure N.V. has a market capitalization of $1.6B, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 69.37M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.

Q:How does QURE's price compare to its book value?

uniQure N.V.'s book value per share is $4.67, while the current stock price is $22.78, resulting in a price-to-book (P/B) ratio of 4.87. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$60.37

165.02% upside potential

Analyst Recommendations

Strong Buy

Buy

Hold

Sell

Strong Sell

Q:How reliable are analyst predictions for QURE?

13 analysts cover QURE with 77% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $60.37 implies 165.0% upside, but targets are often adjusted to follow price moves rather than predict them.

Q:What is the Wall Street consensus on QURE?

Current analyst recommendations:1 Strong Buy, 9 Buy, 3 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Oct 24, 2026, 02:09 AM

Technical Indicators

RSI (14-day)

28.12

Oversold

50-Day Moving Average

$36.97

-38.38% below MA-50

200-Day Moving Average

$29.62

-23.09% below MA-200

MACD Line

-4.14

MACD Signal

-4.89

MACD Histogram

0.76

Bullish

Q:What does QURE's RSI value tell investors?

The RSI (Relative Strength Index) for QURE is currently 28.12, indicating the stock is in oversold territory (below 30). This indicates heavy selling pressure that may have pushed the price too low too fast. Oversold readings can present buying opportunities, but stocks can remain oversold in strong downtrends. Look for RSI to rise above 30 as a potential recovery signal. Combined with the price being below the 50-day moving average, this confirms bearish conditions.

Q:How should traders interpret QURE's MACD and moving average crossovers?

MACD analysis shows the MACD line at -4.14 above the signal line at -4.89, with histogram at 0.76. This bullish crossover suggests upward momentum is building. The 50-day MA ($36.97) is above the 200-day MA ($29.62), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently below both MAs, confirming weakness.

Indicators last updated: Oct 24, 2026, 01:14 AM

Condition	Threshold	Created At
RSI Threshold Cross	30	Sep 28, 2026, 04:20 PM
Earnings Announcement	3 days	Jan 27, 2026, 04:18 PM

Condition

Threshold

Created At

RSI Threshold Cross

Sep 28, 2026, 04:20 PM

Earnings Announcement

3 days

Jan 27, 2026, 04:18 PM

uniQure N.V. (QURE) Stock